Literature DB >> 18221604

Portal vein thrombosis.

Hector Rodriguez-Luna1, Hugo E Vargas.   

Abstract

Portal vein thrombosis (PVT) can be a difficult clinical problem to assess and manage. A high index of suspicion is needed for a PVT diagnosis given the subtle presentation and potentially serious long-term complications. It should be considered a clue to the presence of one or several underlying disorders, including prothrombotic disorders, whether or not a local precipitating factor is identified. The accruing evidence shows that acute PVT can and probably should be treated with anticoagulation or thrombolytic agents in an effort to prevent extension of thrombus, mesenteric vessel occlusion, and portal hypertension. However, chronic PVT should be treated conservatively with measures to control major consequences related to portal hypertension. Anticoagulation therapy duration should be tailored to the identified predisposing factors.

Entities:  

Year:  2007        PMID: 18221604     DOI: 10.1007/s11938-007-0043-x

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  66 in total

1.  Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene.

Authors:  K Brown; R Luddington; D Williamson; P Baker; T Baglin
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

2.  Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation.

Authors:  Ernesto P Molmenti; Thomas W Roodhouse; Hebe Molmenti; Kshama Jaiswal; Ghap Jung; Shigeru Marubashi; Edmund Q Sanchez; Brian Gogel; Marlon F Levy; Robert M Goldstein; Carlos G Fasola; Eric E Elliott; Nevenka Bursac; David Mulligan; Thomas A Gonwa; Goran B Klintmalm
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

Review 3.  Changing perspectives in portal vein thrombosis.

Authors:  H L Janssen
Journal:  Scand J Gastroenterol Suppl       Date:  2000

4.  The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.

Authors:  M Margaglione; G D'Andrea; M d'Addedda; N Giuliani; G Cappucci; L Iannaccone; G Vecchione; E Grandone; V Brancaccio; G Di Minno
Journal:  Thromb Haemost       Date:  1998-05       Impact factor: 5.249

5.  Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy.

Authors:  B Condat; F Pessione; M Helene Denninger; S Hillaire; D Valla
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

6.  The role of anticoagulation in pylephlebitis.

Authors:  N Baril; S Wren; R Radin; P Ralls; S Stain
Journal:  Am J Surg       Date:  1996-11       Impact factor: 2.565

Review 7.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

8.  Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study.

Authors:  H Harada; H Imamura; S Miyagawa; S Kawasaki
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

9.  Evaluation of hepatocyte injury following partial ligation of the left portal vein.

Authors:  M Bilodeau; M C Aubry; R Houle; P N Burnes; C Ethier
Journal:  J Hepatol       Date:  1999-01       Impact factor: 25.083

10.  The spectrum of portal vein thrombosis in liver transplantation.

Authors:  A C Stieber; G Zetti; S Todo; A G Tzakis; J J Fung; I Marino; A Casavilla; R R Selby; T E Starzl
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

View more
  2 in total

1.  Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation.

Authors:  K T Werner; Shawna Sando; Elizabeth J Carey; Hugo E Vargas; Thomas J Byrne; David D Douglas; M E Harrison; Jorge Rakela; Bashar A Aqel
Journal:  Dig Dis Sci       Date:  2013-01-12       Impact factor: 3.199

2.  Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis.

Authors:  Feng-Yong Liu; Mao-Qiang Wang; Qing-Sheng Fan; Feng Duan; Zhi-Jun Wang; Peng Song
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.